Skip to main content

Table 1 Baseline subject characteristics

From: The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids

Subjects treated

50

Most frequent age range

41–45 years of agea

Mean Menstrual Pictogram (MP) score

423 ± 253 (range 119–1582)

Mean UFS-QOL SSS

61.7 ± 16.9 (range 28.1–100.0)

Mean UFS-QOL HRQOL score

34.3 ± 19.0 (range 0.0–73.3)

Total number of target fibroids identified on MRI

118

Mean number of target fibroids per patient

2.4 ± 1.7 (range 1–7)b

Mean diameter of target fibroids

2.9 ± 1.4 cm (range 1.0–6.9 cm)

Mean perfused fibroid volume

18.3 ± 20.6 cm3 (range 0.3–77.0 cm3)

Mean total (perfused + nonperfused) fibroid volume

18.8 ± 21.4 cm3 (range 0.3–77.0 cm3)

  1. UFS-QOL Uterine Fibroid Symptom-Quality of Life Questionnaire, SSS Symptom Severity Score subscale, HRQOL Health-Related Quality of Life subscale
  2. aSubject ages were specified as a range by each site to protect subject privacy
  3. bTwo small additional fibroids, beyond the upper limit of 5 target fibroids/patient, were identified on review of one MRI series after treatment